Dr. Gelfand studies various aspects of orthopedic surgery, looking especially at factors that can affect recovery and patient satisfaction. His research covers conditions such as rotator cuff injuries, foot and ankle fractures, and hand surgeries like carpal tunnel release. He investigates how treatments like testosterone replacement therapy and pain management strategies can change patient outcomes, aiming to make surgeries safer and more effective for patients. He also addresses whether follow-up care is effectively reaching different patient groups, especially those with less social support.
Key findings
Patients on testosterone replacement therapy are 26% more likely to face complications or require additional surgeries after rotator cuff repair.
Only 67.2% of patients with foot and ankle fractures returned for timely orthopedic follow-up, indicating gaps in care, especially for those with lower social support.
Patients receiving low-dose intrathecal morphine post-lumbar fusion surgery required significantly less pain medication (9.7 mg vs. 21.8 mg) compared to those who did not receive it.
After implementing opioid reduction interventions, the average opioid prescription in orthopedic settings dropped by 54.5%, from an average of 27.9 morphine milligram equivalents per patient encounter to 12.7.
Patients who had surgery within 90 days of a COVID-19 diagnosis faced significantly increased risks of complications, like pneumonia, highlighting the need for careful surgery timing.
Frequently asked questions
Does Dr. Gelfand study complications after orthopedic surgeries?
Yes, he specifically researches factors that contribute to complications and recovery after various orthopedic procedures.
What treatments has Dr. Gelfand researched?
He has investigated treatments like testosterone replacement therapy and intrathecal morphine for managing pain and improving outcomes following orthopedic surgeries.
Are his findings relevant for patients recovering from hand surgeries?
Yes, his research includes aspects of hand surgeries such as carpal tunnel release, focusing on how different factors affect recovery and patient experiences.
How does Dr. Gelfand's research benefit patients with fractures?
His studies aim to improve follow-up care, ensuring that patients with fractures, particularly those from underprivileged backgrounds, receive the care they need for better recovery.
Is Dr. Gelfand's work related to pain management?
Absolutely, he focuses on optimizing pain management strategies to enhance recovery and reduce reliance on opioids after surgery.
Publications in plain English
Addressing Barriers to Timely Orthopaedic Follow-up for Foot and Ankle Fractures After Emergency Department Visits.
2026
Foot & ankle specialist
Rana P, Brennan J, Johnson A, Donegan C, Gelfand J +4 more
Plain English This study looked at follow-up care for patients with foot and ankle fractures who visited the emergency department. Out of 1,450 patients, 67.2% returned for orthopedic follow-up, typically within 4.16 days. The research found that people with lower social support, those on Medicaid, and those with certain types of fractures were less likely to follow up, which is concerning because timely care can lead to better recovery.
Who this helps: This helps patients, particularly those with lower income or social support, ensuring they receive necessary follow-up care.
Preoperative testosterone replacement therapy: a potential risk-factor for complications and reoperation after rotator cuff repair.
2026
JSES international
Johnson AH, Friedman R, Brennan JC, Peterman MA, Gelfand J +3 more
Plain English This study looked at the effects of testosterone replacement therapy (TRT) on men who had surgery to repair a rotator cuff. Researchers analyzed data from over 33,000 men, finding that those who had TRT within a year of their surgery were more likely to face complications like being readmitted to the hospital within 90 days (26% more likely), needing additional surgeries, and dealing with other issues like prolonged pain medication use and increased healthcare costs post-surgery. This is important because it suggests that stopping TRT before surgery might reduce the risk of complications for these patients.
Who this helps: Patients undergoing rotator cuff repair who are on testosterone replacement therapy.
Examining the Relationship Between Relative Value Units and Patient-reported Outcomes: Implications for Value-based Care.
2025
The Journal of the American Academy of Orthopaedic Surgeons
Turcotte JJ, Brennan JC, Johnson AH, Patton CM, Gelfand J
Plain English This study looked at how the amount of work doctors do (measured in relative value units or RVUs) relates to how well patients recover after orthopaedic surgery. They found that while there is a strong connection between RVUs and the time spent in surgery, the link between RVUs and patient recovery (measured by a specific outcome score) is weak, with each RVU only explaining about 7% of the improvement in patient function. This matters because as healthcare shifts towards paying based on patient outcomes, it's important to separate the complexity of surgical work from the actual results for patients.
Who this helps: Patients and doctors in orthopaedics.
The Effect of Tourniquet Deflation Timing on Outcomes of Common Upper Extremity Surgeries.
2025
Cureus
Peterman MA, Johnson AH, Wheeler FI, Donegan C, Holmes S +6 more
Plain English This study looked at how the timing of tourniquet removal affects pain and recovery after common upper arm surgeries like carpal tunnel release, trigger finger release, and treatment for wrist fractures. Researchers found that waiting to deflate the tourniquet until after the wound was closed led to longer recovery times and higher pain scores for carpal tunnel patients, with those patients being more likely to need opioids for pain relief. Overall, the timing of tourniquet deflation didn’t significantly impact most recovery outcomes, meaning either timing can be safely used.
Who this helps: This benefits patients undergoing upper extremity surgeries and their doctors in making informed decisions about surgical techniques.
Postoperative Outcomes in Patients Undergoing Orthopaedic Surgery Within 90 Days of Coronavirus Disease 2019.
2023
The Journal of the American Academy of Orthopaedic Surgeons
Johnson AH, Stock LA, Petre BM, Keblish DJ, Gelfand J +4 more
Plain English This study looked at whether patients who had COVID-19 within 90 days before undergoing orthopaedic surgery faced more complications compared to those who hadn’t had COVID-19 recently. The researchers found that patients who had surgery after a recent COVID-19 diagnosis were more likely to experience serious issues like blood clots (venous thromboembolism) and pneumonia. For instance, those who had total joint replacements had a risk of pneumonia that was significantly higher (with a very low chance, P < 0.001) than patients without recent COVID-19.
Who this helps: This information helps doctors make better decisions about surgery timing for patients who have recently recovered from COVID-19.
Disparities in Hand Surgery Exist in Unexpected Populations.
2023
Cureus
Stock LA, Brennan JC, Johnson AH, Gelfand J, Turcotte JJ +1 more
Plain English This study looked at how different factors, like race and marital status, affect the outcomes of two hand surgeries: carpal tunnel release and trigger finger release. Researchers examined 1,172 patients and found that patients who were White, not married, or female often had worse physical function scores before and after surgery compared to others. These findings highlight that certain groups may face more challenges with these common hand surgeries, which could inform better care and support.
Who this helps: This helps patients, particularly those undergoing hand surgeries, by identifying which groups may need more attention and support.
Absorbable Sutures and Telemedicine for Patients Undergoing Trigger Finger Release.
2023
Cureus
Holbert SE, Brown C, Baxter S, Johnson AH, Gelfand J +3 more
Plain English This study looked at 329 patients who had surgery for trigger finger to see if using absorbable stitches and follow-up care through telemedicine could be just as effective as traditional methods. The findings showed that patients who had telemedicine follow-ups were more likely to experience issues like wound complaints, but overall, there were no major differences in post-surgery problems such as pain or the need for further surgery. This matters because it suggests that telemedicine can be a viable option for follow-ups without compromising patient outcomes.
Who this helps: Patients undergoing trigger finger surgery.
The Effect of Preoperative, Low-Dose Intrathecal Morphine on Patient Outcomes Following Lumbar Fusion Surgery: Can We Teach an Old Dog New Tricks?
2023
International journal of spine surgery
Baxter SN, Brennan JC, Johnson AH, Stock L, King R +5 more
Plain English This study examined whether giving patients a low dose of intrathecal morphine before lumbar fusion surgery could improve their pain control and reduce the amount of pain medication they needed afterward. Out of 180 patients, those who received the morphine (65 patients) used significantly less morphine immediately after surgery compared to those who didn't (9.7 mg vs. 21.8 mg). This matters because better pain control can lead to a faster recovery and higher patient satisfaction with their treatment.
Who this helps: Patients undergoing lumbar fusion surgery.
Impact of tranexamic acid on clinical and hematologic outcomes following total shoulder arthroplasty.
2022
Shoulder & elbow
Kelly M, Turcotte J, Fowler MB, West M, Lashgari C +1 more
Plain English This study looked at how a drug called tranexamic acid affects patients after total shoulder surgery. Researchers found that patients who received this drug had less drop in their blood levels after surgery and produced less fluid from the surgical site. While tranexamic acid helped with blood loss, it did not change how long patients stayed in the hospital or their risk of complications.
Who this helps: This benefits patients undergoing shoulder surgery by reducing blood loss.
Counselling patients for return to work on immunosuppression: practices of Canadian specialists during the COVID-19 pandemic.
2021
Clinical and experimental rheumatology
Ladak K, Winthrop K, Marshall JK, Gelfand J, Pope J
Plain English This study looked at how Canadian doctors advise patients taking immunosuppressive medications about returning to work during the COVID-19 pandemic. Out of 151 doctors surveyed, 94% were asked for advice, but only 33% felt confident enough to provide it, and they wrote medical notes to support modified work duties only 25% of the time. This is important because many patients need help balancing their health risks with the need to work, and doctors expressed a clear need for better guidelines on how to handle these situations.
Who this helps: Patients on immunosuppressive medications and their doctors.
Glucocorticoids for therapeutic immunosuppression: Clinical pearls for the practicing neurologist.
2021
Journal of the neurological sciences
Galati A, Brown ES, Bove R, Vaidya A, Gelfand J
Plain English This study looks at the use of glucocorticoids, a type of medication often used to suppress the immune system in neurological diseases. It highlights important guidelines for doctors, including the risks of side effects like high blood pressure, weight gain, and increased risk of infections. Understanding how to safely prescribe and manage these drugs helps protect patients from serious complications.
Who this helps: Patients with neurological diseases who need glucocorticoid treatment.
Irreducible Monteggia Fracture-Dislocation Secondary to an Entrapped Brachialis Tendon: A Case Report.
2021
JBJS case connector
Kelly M, Turcotte J, Shushan A, Gelfand J
Plain English This paper studies a rare case involving a 7-year-old boy who had a specific type of arm fracture and dislocation. After an initial surgery to fix the bone, he continued to have problems with the joint, which were traced back to a tendon that was caught in the wrong place. A second surgery successfully fixed the joint and allowed the boy to move his arm normally again.
Who this helps: This helps doctors understand and treat similar injuries in children.
The impact of opioid prescribing reduction interventions on prescribing patterns across orthopedic subspecialties.
2021
Journal of opioid management
Turcotte J, Crowley K, Adams S, Keblish D, Lashgari C +4 more
Plain English This study looked at how to reduce the amount of opioids prescribed by orthopedic doctors. After implementing several strategies, the average amount of opioids prescribed dropped by 54.5%, from 27.9 to 12.7 milligrams per patient, and the number of pills per prescription decreased by nearly 30%. This is important because it helps lessen the risk of addiction and improves patient safety.
Who this helps: This benefits patients, especially those undergoing orthopedic procedures.
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.
2020
The Journal of infectious diseases
Naranbhai V, Chang CC, Beltran WFG, Miller TE, Astudillo MG +18 more
Plain English This study looked at the presence of COVID-19 antibodies in Chelsea, Massachusetts, a community heavily impacted by the virus. Researchers found that 31.5% of the 200 residents tested had antibodies, indicating they had been infected with the virus previously, even though many did not show any symptoms at the time. This finding is important because it reveals a high level of hidden infections in the community, which is crucial for understanding how the virus spreads.
Who this helps: This helps public health officials and community leaders in managing COVID-19 responses.
Case Report: OverwhelmingParasitemia Successfully Treated Promptly With RBC Apheresis and Triple Therapy With Clindamycin, Azithromycin, and Atovaquone.
2020
Open forum infectious diseases
Li Y, Stanley S, Villalba JA, Nelson S, Gelfand J
Plain English This study looked at a patient without a spleen who had a very high level of parasites in their blood due to a disease called babesiosis, specifically over 50% parasitemia. The patient was successfully treated using a method to remove red blood cells combined with three antibiotics: clindamycin, azithromycin, and atovaquone. This approach might be a better option for treating severe cases than a commonly used treatment that many find difficult to tolerate.
Who this helps: This helps patients with severe babesiosis, especially those without a spleen.
Opioid Prescribing Guidelines for Arthroscopic Partial Meniscectomy Based on Patient-reported Opioid Consumption.
2020
Journal of surgical orthopaedic advances
Turcotte J, Taylor S, Palsgrove A, Gelfand J, Petre B +1 more
Plain English This study looked at how many opioid pain pills are needed after arthroscopic partial meniscectomy surgery. Researchers found that patients were often given too many pills—on average, they were prescribed about 16 pills but only took about 4. The study suggests that doctors should only prescribe 5 opioid pills, which is all most patients really need for pain relief after this type of surgery.
Who this helps: This helps patients recovering from arthroscopic surgery by ensuring they receive safer, more appropriate pain management.
A comparison of PROMIS Global Health-Mental and legacy orthopedic outcome measures for evaluating preoperative mental health status.
2020
Journal of orthopaedics
Palsgrove A, Patton C, King P, Gelfand J, Turcotte J
Plain English This study looked at how well different questionnaires measure mental health in patients before surgery. Researchers found that scores from physical health measures were more closely related to traditional mental health questionnaires than the specific mental health measure used in the study. This matters because understanding these differences can help doctors better assess and address mental health issues in surgical patients.
Who this helps: This helps doctors and patients preparing for surgery.
Brief Exposure of Skin to Near-Infrared Laser Modulates Mast Cell Function and Augments the Immune Response.
2018
Journal of immunology (Baltimore, Md. : 1950)
Kimizuka Y, Katagiri W, Locascio JJ, Shigeta A, Sasaki Y +11 more
Plain English Researchers studied how a low-power near-infrared laser could improve the immune response when applied to the skin before vaccination. They found that this laser temporarily activates certain immune cells called mast cells, leading to a better immune reaction without causing lasting inflammation. This method is safe, simple, and could replace chemical additives commonly used in vaccines that may cause side effects.
Who this helps: Patients receiving vaccines, particularly those with immune-related skin conditions.
Kimizuka Y, Callahan JJ, Huang Z, Morse K, Katagiri W +19 more
Plain English Researchers studied a new handheld laser device that enhances the immune response to vaccines when used on the skin. They found that this low-cost device, which uses semiconductor diodes and costs less than $4000, produced similar immune-boosting effects as more expensive systems, showing promise for better vaccination outcomes. This method could simplify and lower the costs of vaccine delivery, making it easier to implement in public health programs.
Who this helps: This benefits patients and public health programs by improving vaccine effectiveness.
Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine.
2017
Journal of immunology (Baltimore, Md. : 1950)
Morse K, Kimizuka Y, Chan MPK, Shibata M, Shimaoka Y +19 more
Plain English Researchers studied how a special type of near-infrared laser light can enhance the body's immune response to a flu vaccine delivered under the skin. They found that using a continuous wave version of the laser improved the activity of certain immune cells called migratory dendritic cells (DCs) and increased the effectiveness of the vaccine significantly compared to using a pulsed version of the laser. This matters because it shows that adjusting the laser's settings can make vaccines more effective by better activating the immune system.
Who this helps: This helps patients by potentially improving vaccine responses.
Secukinumab treatment of plaque psoriasis shows early improvement in DLQI response - results of a phase II regimen-finding trial.
2016
Journal of the European Academy of Dermatology and Venereology : JEADV
Augustin M, Abeysinghe S, Mallya U, Qureshi A, Roskell N +3 more
Plain English This study looked at how different treatment schedules of secukinumab, a medication for psoriasis, affect the quality of life in patients with moderate to severe psoriasis. After 12 weeks, patients who received the early and monthly doses of secukinumab saw significant improvements in their health-related quality of life, with response rates of 40.8% and 33.6%, compared to just 1.6% for those who received a placebo. This is important because psoriasis can heavily impact daily life, and these findings suggest that timely treatment can lead to better overall well-being for patients.
Who this helps: Patients suffering from moderate to severe psoriasis.
GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo.
2016
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Singh P, González-Ramos S, Mojena M, Rosales-Mendoza CE, Emami H +9 more
Plain English This study looked at how a substance called GM-CSF affects the activity of immune cells known as macrophages, particularly their energy use and ability to detect inflammation. Researchers found that GM-CSF increased the energy use of these cells by about 70% in mice and rabbits with inflamed arteries, but not in healthy ones. This is important because it suggests GM-CSF could help improve the detection of inflammation in diseases like atherosclerosis, which can lead to heart problems.
Who this helps: Patients with inflammatory diseases, particularly cardiovascular conditions.
Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients.
2015
Neurology
Höftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M +7 more
Plain English This study looked at 22 patients with a specific type of autoimmune encephalitis caused by antibodies to AMPA receptors, which are important for brain function. The researchers found that 55% of the patients had a unique condition called limbic encephalitis, and 64% of them also had tumors related to their symptoms. Most patients showed some level of improvement with treatment, but unfortunately, 5 of them died due to their tumors or related health issues.
Who this helps: This helps patients with encephalitis and their doctors in making better diagnosis and treatment plans.
A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma.
2014
Journal of hematology & oncology
Yuan J, Kashiwagi S, Reeves P, Nezivar J, Yang Y +18 more
Plain English This study focused on a new cancer treatment that combines a protein from tuberculosis with an antibody that targets mesothelin, a molecule found in high amounts on certain cancer cells. In tests with mice, the treatment not only improved survival rates but also slowed tumor growth and boosted the body's immune response against the cancer. Specifically, mice receiving this treatment showed a significant increase in survival times and better immune responses compared to others.
Who this helps: This approach benefits cancer patients, particularly those with ovarian cancer and mesothelioma.
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
2014
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Judson MA, Costabel U, Drent M, Wells A, Maier L +22 more
Plain English Researchers updated a tool used to evaluate how sarcoidosis affects different organs in the body, as the old tool was becoming outdated. The new instrument classifies organ involvement based on expert consensus, with categories such as "highly probable," where the chance is over 90%, and "possible," where it's under 50%. This new tool will improve how doctors assess and understand the impact of sarcoidosis on patients, making diagnoses more accurate.
Who this helps: This benefits doctors and patients with sarcoidosis.
Laser vaccine adjuvants. History, progress, and potential.
2014
Human vaccines & immunotherapeutics
Kashiwagi S, Brauns T, Gelfand J, Poznansky MC
Plain English This paper studies the use of safe laser light as a way to enhance the effectiveness of vaccines, especially those delivered just under the skin (intradermal vaccines). The researchers found that using a special near-infrared laser improved immune responses to vaccines, showing promise for future vaccines to be both safe and effective. This is important because currently available vaccine boosters, known as adjuvants, are limited in their safety and effectiveness, making this new approach a potential game-changer for vaccine development.
Who this helps: Patients receiving vaccines, particularly those needing intradermal administration.
Reply: Microcysts in the inner nuclear layer from optic atrophy are caused by retrograde trans-synaptic degeneration combined with vitreous traction on the retinal surface.
Near-infrared laser adjuvant for influenza vaccine.
2013
PloS one
Kashiwagi S, Yuan J, Forbes B, Hibert ML, Lee EL +17 more
Plain English This study looked at using a special type of laser light to boost the effectiveness of influenza vaccines given through the skin. The researchers found that this near-infrared laser increased immune responses without causing harmful side effects and improved protection against the flu in mice. This is important because it offers a new, safe, and cost-effective way to enhance vaccine effectiveness without needing extra chemicals.
Who this helps: Patients and healthcare providers.
Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A
Plain English This study looked at how color vision relates to damage in the eyes of people with Multiple Sclerosis (MS). Researchers found that MS patients not only had lower scores on standard vision tests but also faced significant issues with color discrimination—worse than what standard measures would show. Specifically, there was a strong link between color vision problems and the thinning of important eye structures, suggesting that tests of color vision can be useful in tracking MS progression.
Who this helps: This research benefits patients with MS and their doctors by providing new tools to assess eye health and disease progression.
Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.
2007
The Journal of biological chemistry
Li W, Marshall C, Mei L, Gelfand J, Seykora JT
Plain English This study looked at how a protein called Srcasm helps control the activity of another protein, Fyn, which can lead to excessive skin cell growth. In mice with high levels of Fyn, the skin became thicker and showed signs of overgrowth, but when these mice also had increased levels of Srcasm, the skin condition improved, with Fyn levels decreasing. Understanding how Srcasm regulates Fyn is important because it could lead to new ways to treat skin diseases caused by too much growth.
Who this helps: This benefits patients with skin conditions related to cell overgrowth.
Plain English This study looked at how well the Psoriasis Disability Index (PDI) measures the effects of psoriasis on patients in the United States, examining responses from 1,196 individuals. The researchers found that while the PDI is consistently reliable, it does not effectively capture mild limitations caused by psoriasis, and its current design may not provide a clear overall score since it measures different aspects of the condition. This matters because using an inadequate tool could hinder understanding of how psoriasis affects patients' lives, making it harder to provide proper care and support.
Who this helps: Patients with psoriasis and their healthcare providers.
Familial basaloid follicular hamartoma: lesional characterization and review of the literature.
2003
The American Journal of dermatopathology
Jih DM, Shapiro M, James WD, Levin M, Gelfand J +4 more
Plain English This research focused on basaloid follicular hamartoma (BFH), a rare skin condition that appears as small, stable bumps. The study found that BFH lesions have different characteristics compared to basal cell carcinoma (BCC), including fewer signs of cell growth and damage, suggesting they are less aggressive. Understanding these differences is important because it helps avoid unnecessary surgery for patients when BFH is mistakenly diagnosed as BCC.
Who this helps: This benefits patients with basaloid follicular hamartoma by providing clearer diagnosis and treatment options.
Oscillations in the alpha band (9-12 Hz) increase with memory load during retention in a short-term memory task.
2002
Cerebral cortex (New York, N.Y. : 1991)
Jensen O, Gelfand J, Kounios J, Lisman JE
Plain English This study looked at how brain waves, specifically in the alpha range (9-12 Hz), change when people try to remember more items in a memory task. Researchers found that as the number of items to remember increased, the strength of the alpha waves also increased, showing that these waves support memory retention rather than just indicating idle brain activity. This matters because it helps us understand how the brain manages working memory and could lead to better approaches for addressing memory-related issues.
Who this helps: This helps researchers and clinicians working on memory-related conditions and therapies.
Interstitial cystitis and bladder mastocytosis in a woman with chronic urticaria.
1997
Scandinavian journal of urology and nephrology
Sant GR, Theoharides TC, Letourneau R, Gelfand J
Plain English The study examined a woman who had chronic hives and swelling, and also discovered she had a painful bladder condition called interstitial cystitis. A biopsy of her bladder showed an unusually high number of mast cells (over 60 per square millimeter, compared to the normal count of less than 10), indicating inflammation. This finding suggests that mast cells play a role in the development of interstitial cystitis, which is important for understanding how to treat the condition.
Who this helps: This information benefits patients suffering from interstitial cystitis and doctors treating them.
Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor.
1994
Journal of immunology (Baltimore, Md. : 1950)
Mandle R, Baron C, Roux E, Sundel R, Gelfand J +4 more
Plain English This study explored a specific case of a patient who developed a deficiency in a protein called C1 inhibitor, which is important for regulating immune responses. Researchers found that the patient's body created an autoantibody that interferes with the C1 inhibitor's ability to function properly, blocking its action in a dose-dependent manner. The significance of this finding lies in understanding how certain autoantibodies can disrupt normal immune system operations, which could lead to better diagnosis and treatment of similar conditions.
Who this helps: This helps patients with immune system disorders and their doctors.
The International journal of oral & maxillofacial implants
Perala D, Chapman R, Gelfand J
Plain English This study looked at how dental implants activate a part of the immune system called the complement system. Researchers found that all the dental implants tested caused significant activation, which could affect healing in either a positive or negative way. This is important because it helps us understand how implants might influence recovery after dental procedures.
Who this helps: Patients getting dental implants.
Littman MG, Liker M, Stubbeman W, Russakow J, McGee C +2 more
Plain English This study looked at how basic reflexes in the human body work together to create muscle movements that feel springy and stable. Researchers found that two key reflexes—stretch and tendon reflexes—help muscles maintain the right tension and length, making them feel more natural. This research is important because understanding these reflexes can improve the design of artificial muscles, making them more effective for robotics and prosthetics.
Who this helps: This benefits patients who use prosthetics and doctors involved in rehabilitation.
De novo membranous glomerulonephropathy in renal allografts: a report of ten cases and review of the literature.
1989
American journal of kidney diseases : the official journal of the National Kidney Foundation
Truong L, Gelfand J, D'Agati V, Tomaszewski J, Appel G +2 more
Plain English This study examined ten kidney transplant patients who developed a condition called de novo membranous glomerulonephropathy (MGN), which is common after a kidney transplant. The researchers found that about half of the transplanted kidneys affected by this condition eventually failed. This is concerning because it indicates that MGN in transplant patients may often be linked to issues with the body's rejection of the new organ rather than just being a separate health problem.
Who this helps: This information benefits doctors and kidney transplant patients by highlighting potential complications after surgery.
Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.
1986
American journal of kidney diseases : the official journal of the National Kidney Foundation
Valeri A, Gelfand J, Blum C, Appel GB
Plain English This study looked at how diet and two medications, colestipol and probucol, affected cholesterol levels in patients with nephrotic syndrome, a condition that often leads to high cholesterol. Colestipol reduced total cholesterol by about 20% and LDL (bad cholesterol) by about 32%, while probucol lowered total cholesterol by about 23% and LDL by nearly 24%. These findings are important because managing cholesterol levels can help reduce the risk of heart problems in these patients.
Who this helps: This helps patients with nephrotic syndrome and their doctors.
Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion.
1985
American journal of kidney diseases : the official journal of the National Kidney Foundation
Gelfand J, Truong L, Stern L, Pirani CL, Appel GB
Plain English This study looked at two patients with systemic lupus erythematosus who showed symptoms similar to a serious blood condition called thrombotic thrombocytopenic purpura. They both experienced low platelet counts, severe anemia, seizures, and kidney problems. Traditional treatments didn't work, but infusing fresh frozen plasma significantly improved their condition, showing that this therapy can be effective for lupus patients experiencing these symptoms.
Who this helps: This helps patients with systemic lupus erythematosus and their doctors by providing an effective treatment option for related complications.
Plain English This study examined the effects of Danazol on seven patients with systemic lupus erythematosus (SLE), a condition that can cause various health issues. The results showed that Danazol led to a decrease in harmful antibodies, an increase in healthy blood platelets, and improvements in patient symptoms, particularly for those with mild disease activity. Importantly, the side effects of the drug were minimal, making it a potential option for some SLE patients, while not effective for those with severe cases.
Who this helps: This benefits patients with mild systemic lupus erythematosus and their doctors.
Justin Turcotte Andrea H Johnson Mark C Poznansky Timothy Brauns Satoshi Kashiwagi Jane C Brennan Justin J Turcotte Kosuke Tsukada Cyrus Lashgari Christopher Jones
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.